Stockreport

iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion [Yahoo! Finance]

Insight Molecular Diagnostics Inc.  (IMDX) 
PDF GraftAssureDx™ FDA IVD approval application 95% complete at year-end; expect full submission in coming weeks Accelerating planned UK CE mark and EU IVDR submission to [Read more]